Table 3.
Samples | Significance (P-values) | ||||
---|---|---|---|---|---|
Dose (μM) HydrogenPeroxide | 0 | 50 | 100 | 150 | 250 |
Untransfected vs. Low | 0.99 (NS) | 0.15 (NS) | 0.028 | 0.106 (NS) | 0.0001 |
Untransfected vs. Medium | 0.99 (NS) | 0.80 (NS) | 0.1 (NS) | 0.086 (NS) | 0.0004 |
Untransfected vs. High A | 0.99 (NS) | 0.22 (NS) | 0.019 | 0.013 | 0.0001 |
Untransfected vs. High B | 0.99 (NS) | 0.66 (NS) | 0.16 | 0.52 (NS) | 0.0003 |
Dose (μM) Cobalt Chloride | 0 | 50 | 100 | 150 | 200 |
Untransfected vs. Low | 0.99 (NS) | 0.0005 | 0.98 (NS) | 0.058 (NS) | 0.0001 |
Untransfected vs. Medium | 0.99 (NS) | 0.94 (NS) | 0.4 (NS) | 0.048 | 0.0001 |
Untransfected vs. High A | 0.99 (NS) | 0.006 | 0.61 (NS) | 0.30 (NS) | 0.0001 |
Untransfected vs. High B | 0.99 (NS) | 0.46 (NS) | 0.99 (NS) | 0.01(NS) | 0.0001 |
Summary of results between clones as illustrated in Figure 6E (hydrogen peroxide) and Figure 6F (cobalt chloride) after 24 h treatment. Results analyzed by Two-Way Analysis of Variance with Tukey's post-hoc test. Results are compiled from three separate experiments. NS, not significant statistically.